Science Corporation implants PRIMA vision chip in first Stargardt patient
The tiny retina implant, already sold in Europe for one eye condition, is now in a trial for an inherited disease.
A tiny chip placed in the eye helps some people see again with special glasses. A man with an inherited eye disease now has one. He can read a word. It is early and tested in one person.
2 mmchip size
Hype check
Hype4
Real2
The noise matches the real change.
Our editorial opinion, based on the sources below. How we score
Why it matters
Early results come from one person, but they show a possible new use for a chip that already exists.
For most people
Worth a look: hopeful early science.
The details
- TechCrunch reports the implant was placed in May 2026 at Sydney Eye Hospital in Australia.
- PRIMA is a 2 mm by 2 mm chip under the retina, used with camera glasses.
- It is sold in Europe for geographic atrophy, an advanced form of age-related macular degeneration.
- In rehab, the patient saw a letter, then read a word; these are company-reported results.
- The view is small and black and white; a wider view needs a larger implant.
Receipts
One trusted outlet reports it. Not confirmed yet. Open the sources and check us.
Written with the help of AI tools and checked against the sources above. How we work
See a mistake? Tell us and we’ll fix it.
